Gerard M. Jensen

913 total citations
17 papers, 750 citations indexed

About

Gerard M. Jensen is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Gerard M. Jensen has authored 17 papers receiving a total of 750 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 5 papers in Molecular Biology and 4 papers in Epidemiology. Recurrent topics in Gerard M. Jensen's work include Antifungal resistance and susceptibility (7 papers), Nanoparticle-Based Drug Delivery (3 papers) and Fungal Infections and Studies (3 papers). Gerard M. Jensen is often cited by papers focused on Antifungal resistance and susceptibility (7 papers), Nanoparticle-Based Drug Delivery (3 papers) and Fungal Infections and Studies (3 papers). Gerard M. Jensen collaborates with scholars based in United States, United Kingdom and Australia. Gerard M. Jensen's co-authors include David B. Goodin, Jill Adler‐Moore, Jon Olson, Steven W. Bunte, R.J. Rosenfeld, Rabi A. Musah, Duncan E. McRee, Richard T. Proffitt, Julie Schwartz and Prashant Sood and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Journal of Molecular Biology.

In The Last Decade

Gerard M. Jensen

17 papers receiving 734 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gerard M. Jensen United States 15 272 205 166 76 69 17 750
Sharma R. Minchey United States 14 391 1.4× 159 0.8× 83 0.5× 150 2.0× 100 1.4× 20 785
Joanna Barwicz Canada 13 414 1.5× 145 0.7× 62 0.4× 43 0.6× 131 1.9× 17 717
Ernesto R. Caffarena Brazil 18 445 1.6× 123 0.6× 140 0.8× 96 1.3× 215 3.1× 73 1.1k
Salman Muzammil United States 15 795 2.9× 200 1.0× 45 0.3× 35 0.5× 109 1.6× 21 1.2k
Wael M. Elshemey Egypt 19 281 1.0× 227 1.1× 130 0.8× 128 1.7× 85 1.2× 84 1.1k
Ilona Gruda Canada 18 302 1.1× 165 0.8× 67 0.4× 37 0.5× 200 2.9× 34 909
Leila Zarif France 18 346 1.3× 190 0.9× 140 0.8× 152 2.0× 256 3.7× 37 1.0k
Jean L. Whittingham United Kingdom 17 604 2.2× 116 0.6× 39 0.2× 36 0.5× 72 1.0× 27 914
Kata Horváti Hungary 18 578 2.1× 151 0.7× 81 0.5× 87 1.1× 300 4.3× 52 944
M. A. Alsina Spain 19 965 3.5× 68 0.3× 215 1.3× 176 2.3× 211 3.1× 134 1.5k

Countries citing papers authored by Gerard M. Jensen

Since Specialization
Citations

This map shows the geographic impact of Gerard M. Jensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerard M. Jensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerard M. Jensen more than expected).

Fields of papers citing papers by Gerard M. Jensen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerard M. Jensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerard M. Jensen. The network helps show where Gerard M. Jensen may publish in the future.

Co-authorship network of co-authors of Gerard M. Jensen

This figure shows the co-authorship network connecting the top 25 collaborators of Gerard M. Jensen. A scholar is included among the top collaborators of Gerard M. Jensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerard M. Jensen. Gerard M. Jensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Jensen, Gerard M., et al.. (2020). Opportunities and challenges in commercial pharmaceutical liposome applications. Advanced Drug Delivery Reviews. 154-155. 2–12. 64 indexed citations
2.
Walker, Louise A., Prashant Sood, Megan D. Lenardon, et al.. (2018). The Viscoelastic Properties of the Fungal Cell Wall Allow Traffic of AmBisome as Intact Liposome Vesicles. mBio. 9(1). 136 indexed citations
3.
Jensen, Gerard M.. (2017). The care and feeding of a commercial liposomal product: liposomal amphotericin B (AmBisome®). Journal of Liposome Research. 27(3). 173–179. 23 indexed citations
4.
5.
Lestner, Jodi M., Susan J. Howard, Joanne Goodwin, et al.. (2010). Pharmacokinetics and Pharmacodynamics of Amphotericin B Deoxycholate, Liposomal Amphotericin B, and Amphotericin B Lipid Complex in an In Vitro Model of Invasive Pulmonary Aspergillosis. Antimicrobial Agents and Chemotherapy. 54(8). 3432–3441. 51 indexed citations
6.
Jensen, Gerard M., et al.. (2007). Conventional Liposome Performance and Evaluation: Lessons from the Development of Vescan. Journal of Liposome Research. 17(3-4). 121–137. 25 indexed citations
7.
Olson, Jon, Jill Adler‐Moore, Gerard M. Jensen, et al.. (2007). Comparison of the Physicochemical, Antifungal, and Toxic Properties of Two Liposomal Amphotericin B Products. Antimicrobial Agents and Chemotherapy. 52(1). 259–268. 58 indexed citations
8.
Olson, Jon, Jill Adler‐Moore, Julie Schwartz, Gerard M. Jensen, & Richard T. Proffitt. (2006). Comparative Efficacies, Toxicities, and Tissue Concentrations of Amphotericin B Lipid Formulations in a Murine Pulmonary Aspergillosis Model. Antimicrobial Agents and Chemotherapy. 50(6). 2122–2131. 59 indexed citations
9.
Jensen, Gerard M., et al.. (2004). New liposomal formulations of cisplatin with improved therapeutic index. 64. 1065–1065. 3 indexed citations
10.
Musah, Rabi A., Gerard M. Jensen, Steven W. Bunte, R.J. Rosenfeld, & David B. Goodin. (2002). Artificial protein cavities as specific ligand-binding templates: characterization of an engineered heterocyclic cation-binding site that preserves the evolved specificity of the parent protein 1 1Edited by R. Huber. Journal of Molecular Biology. 315(4). 845–857. 47 indexed citations
11.
Garey, Kevin W., et al.. (2001). Cunninghamella bertholletiae Infection in a Bone Marrow Transplant Patient: Amphotericin Lung Penetration, MIC Determinations, and Review of the Literature. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 21(7). 855–860. 25 indexed citations
12.
Liu, Kai, John R. Williams, Melissa M. Fitzgerald, et al.. (1998). Solid-State Deuterium NMR of Imidazole Ligands in Cytochrome c Peroxidase. Journal of the American Chemical Society. 120(39). 10199–10202. 35 indexed citations
13.
Musah, Rabi A., Gerard M. Jensen, R.J. Rosenfeld, et al.. (1997). Variation in Strength of an Unconventional C−H to O Hydrogen Bond in an Engineered Protein Cavity. Journal of the American Chemical Society. 119(38). 9083–9084. 101 indexed citations
14.
Ryle, Matthew J., William N. Lanzilotta, Lance C. Seefeldt, Robert C. Scarrow, & Gerard M. Jensen. (1996). Circular Dichroism and X-ray Spectroscopies of Azotobacter vinelandii Nitrogenase Iron Protein. Journal of Biological Chemistry. 271(3). 1551–1557. 41 indexed citations
15.
Wilcox, Sheri K., Gerard M. Jensen, Melissa M. Fitzgerald, Duncan E. McRee, & David B. Goodin. (1996). Altering Substrate Specificity at the Heme Edge of CytochromecPeroxidase. Biochemistry. 35(15). 4858–4866. 15 indexed citations
16.
Fitzgerald, Melissa M., et al.. (1995). The role of aspartate-235 in the binding of cations to an artificial cavity at the radical site of cytochromecperoxidase. Protein Science. 4(9). 1844–1850. 28 indexed citations
17.
Jensen, Gerard M., et al.. (1992). effects of insulin on aldosterone production in rat zona glomerulosa cells. Life Sciences. 50(23). 1781–1787. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026